| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
Aquestive Therapeutics (NASDAQ:AQST) is gearing up to announce its quarterly earnings on Monday, 2025-08-11. Here's a quick overview of what investors should know before the release.
Analysts are estimating that Aquestive Therapeutics will report an earnings per share (EPS) of $-0.18.
Anticipation surrounds Aquestive Therapeutics's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.
New investors should understand that while earnings performance is important, market reactions are often driven by guidance.
The company's EPS missed by $0.08 in the last quarter, leading to a 19.65% drop in the share price on the following day.
Here's a look at Aquestive Therapeutics's past performance and the resulting price change:
| Quarter | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| EPS Estimate | -0.16 | -0.13 | -0.13 | -0.12 |
| EPS Actual | -0.24 | -0.19 | -0.13 | -0.03 |
| Price Change % | -20.0% | -8.0% | -8.0% | 1.0% |
Shares of Aquestive Therapeutics were trading at $3.93 as of August 07. Over the last 52-week period, shares are up 13.82%. Given that these returns are generally positive, long-term shareholders should be satisfied going into this earnings release.
To track all earnings releases for Aquestive Therapeutics visit their earnings calendar on our site.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Posted In: AQST
